RHOA and melanoma: It is also noteworthy that in a limited number of PDTXs models that were developed by the implantation of human melanoma specimens, following surgical removal from patients tumour into an NSG mouse, the combined opposite targeting of p110δ PI3K and RhoA also abolished melanoma progression (Fig. 4d).